7 – 9 December 2022
The TREAT-NMD Alliance are organising our 7th international conference focussing on translational medicine in inherited neuromuscular diseases to be held from 7th-9th December 2022 in Vancouver in Canada.
The aim of this international conference will be to share progress and lessons learned in the area of translational medicine in inherited neuromuscular diseases and plan for the delivery of future therapies to patients.
The conference will attract over 300 delegates including academics, patients and carers, patient advocacy organisations and clinical specialists.
TREAT-NMD would like to thank our individual members who shared their thoughts and ideas on the organisation of the 2022 conference.
Day 1 – 8th December 2022
SESSION ONE: Patient engagement
SESSION TWO: Patient engagement and clinical trial considerations in ultra-rare patient groups
SESSION THREE: Global Neuromuscular Care and Trial Considerations
7pm Networking event
7.45pm Keynote speaker: Geralyn Miller, AI for good Research Lab
Day 2 – 9th December 2022
SESSION FOUR: COVID impact on Outcomes, Care & Clinical Trial Design
SESSION FIVE: Living with NMD: practical considerations and QOL
SESSION SIX: Emerging Therapeutics options in NMD
SESSION SEVEN: Future of clinical trial Design
The full conference programme will be available soon.
The website provides information on the conference location, the agenda, opportunities for sponsorship and much more.
